New study checks if HIV prevention shots and contraceptives mix safely
NCT ID NCT07516548
First seen Apr 14, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at how a long-acting injectable HIV prevention drug (CAB-LA) and hormonal birth control methods affect each other in women. About 105 women who already use CAB-LA or no HIV prevention will choose to use an injectable contraceptive, an implant, or no hormonal birth control. Researchers will take blood samples over 12 to 24 weeks to measure drug and hormone levels, and check for side effects and satisfaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Marina Hospital
Bontleng, Gaborone, Botswana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.